Appili Therapeutics strikes funding deal with The Lind Partners
Halifax, Nova Scotia-based Appili Therapeutics, an infectious disease biopharmaceutical company, has collected C$3.5 million in a convertible security financing agreement.
Halifax, Nova Scotia-based Appili Therapeutics, an infectious disease biopharmaceutical company, has collected C$3.5 million in a convertible security financing agreement.
Copyright PEI Media
Not for publication, email or dissemination
